Skip to content

Pharmacology, Biochemistry, and Behavior

ISSN 1873-5177, 0091-3057

325 papers in the library · 3,738 citations · publishing 1975-2026

Papers

Sort Most recent Most cited

Further evidence that the delayed temporal dopaminergic effects of LSD are mediated by a mechanism different than the first temporal phase of action.

Pharmacology, Biochemistry, and Behavior October 2007 Danuta Marona‐lewicka, David E Nichols

Activation of 5-HT(2A) receptors is thought to mediate the hallucinogenic effects of LSD. Nevertheless, in a previous report we provided evidence that a delayed temporal phase of the behavioral pharmacology of LSD is mediated by D(2)-like dopamine receptor stimulation. In this study rats were trained to discriminate LSD with either a 30 min preinjection time (LSD-30, N=12) or a 90 min...

The stimulus effects of 8-OH-DPAT: evidence for a 5-HT2A receptor-mediated component.

Pharmacology, Biochemistry, and Behavior September 19, 2007 Chad J Reissig, Justin R Eckler, R A Rabin et al.

A previous investigation in our laboratory found that the stimulus effects of the 5-HT2A agonist, LSD, are potentiated by 5-HT1A receptor agonists including the prototypic agonist, 8-OH-DPAT. Also suggestive of behaviorally relevant interactions between 5-HT1A and 5-HT2A receptors are behavioral analyses of locomotor activity, head-twitch response, forepaw treading and production of the...

N-Methyl-1-(4-methoxyphenyl)-2-aminopropane (PMMA) and N-Methyl-1-(3,4-methylenedioxyphenyl)-2-aminopropane (MDMA) produce non-identical discriminative stimuli in rats.

Pharmacology, Biochemistry, and Behavior March 2007 Richard A Glennon, Richard Young, Małgorzata Dukat et al.

N-Methyl-1-(3,4-methylenedioxyphenyl)-2-aminopropane (methylenedioxymethamphetamine, MDMA, Ecstasy) and its structurally abbreviated congener N-methyl-1-(4-methoxyphenyl)-2-aminopropane (para-methoxymethamphetamine, PMMA) are chemically related designer drugs, and PMMA is sometimes sold on the clandestine market as a substitute for MDMA. Prior drug discrimination studies have found that MDMA...

Social stimuli enhance phencyclidine (PCP) self-administration in rhesus monkeys.

Pharmacology, Biochemistry, and Behavior 2007 Jennifer L Newman, Jennifer L Perry, Marilyn E Carroll

Environmental factors, including social interaction, can alter the effects of drugs of abuse on behavior. The present study was conducted to examine the effects of social stimuli on oral phencyclidine (PCP) self-administration by rhesus monkeys. Ten adult rhesus monkeys (M. mulatta) were housed side by side in modular cages that could be configured to provide visual, auditory, and olfactory...

alpha-Ethyltryptamine (alpha-ET) as a discriminative stimulus in rats.

Pharmacology, Biochemistry, and Behavior October 1, 2006 Richard A Glennon, Tatiana Bondareva, Richard Young

alpha-Ethyltryptamine (etryptamine, alpha-ET) is a drug of abuse that first appeared on the clandestine market in the mid-1980s. Its pharmacological actions are poorly understood. In this investigation, it is reported for the first time that alpha-ET serves as a training drug in drug discrimination studies. Male Sprague-Dawley rats were trained to discriminate (30-min pretreatment time) 2.5...

A study of the role of serotonin in the anxiolytic effect of nitrous oxide in rodents.

Pharmacology, Biochemistry, and Behavior June 1, 2006 Dimitris E Emmanouil, Z Papadopoulou-Daifoti, Philip T Hagihara et al.

In earlier studies, we have shown that nitrous oxide (N2O)-induced behavioral effects in rats and mice are mediated by benzodiazepine receptors. This two-part study was conducted in order to investigate the possible role of serotonin (5-HT) in the behavioral effects of N2O by clarifying its effects on regional brain concentrations of 5-HT and assessing the influence of 5-HT antagonist and...

Hallucinogen-like actions of 5-methoxy-N,N-diisopropyltryptamine in mice and rats.

Pharmacology, Biochemistry, and Behavior 2006 William E Fantegrossi, A W Harrington, C L Kiessel et al. 144 citations

Few studies have examined the effects of 5-methoxy-N,N-diisopropyltryptamine (5-MeO-DIPT) in vivo. In these studies, 5-MeO-DIPT was tested in a drug-elicited head twitch assay in mice where it was compared to the structurally similar hallucinogen N,N-dimethyltryptamine (N,N-DMT) and challenged with the selective serotonin (5-HT)2A antagonist M100907, and in a lysergic acid diethylamide (LSD)...

Acute and chronic effects of MDMA on molecular mechanisms implicated in memory formation in rat hippocampus: surface expression of CaMKII and NMDA receptor subunits.

Pharmacology, Biochemistry, and Behavior September 9, 2005 S. Moyano, J. Del Río, D. Frechilla 29 citations

Acute 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") treatment induces learning deficits in different animal models. In a passive avoidance learning task in rats, previous studies suggested a role for Ca2+/calmodulin-dependent protein kinase II (CaMKII) and N-methyl-D-aspartate (NMDA) receptors in the acute learning impairment. As cognitive deficits by "ecstasy" in humans have been only...

DOI: 10.1016/j.pbb.2005.07.020 (opens in new tab) Hippocampus Animals Rats, wistar N-methyl-3,4-methylenedioxyamphetamine +6

The stimulus properties of LSD in C57BL/6 mice.

Pharmacology, Biochemistry, and Behavior August 2005 Jerrold C Winter, A K Kieres, M D Zimmerman et al.

Drug-induced stimulus control has proven to be a powerful tool for the assessment of a wide range of psychoactive drugs. Although a variety of species has been employed, the majority of studies have been in the rat. However, with the development of techniques which permit the genetic modification of mice, the latter species has taken on new importance. Lysergic acid diethylamide [LSD], the...

Serotonergic/glutamatergic interactions: potentiation of phencyclidine-induced stimulus control by citalopram.

Pharmacology, Biochemistry, and Behavior July 2005 Jerrold C Winter, Justin R Eckler, K C Rice et al.

Previous investigations in our laboratory have found that the stimulus effects of the hallucinogenic serotonergic agonists DOM and LSD are potentiated by phencyclidine [PCP], a non-competitive NMDA antagonist. Also suggestive of behaviorally significant serotonergic/glutamatergic interactions is our finding that stimulus control by both PCP and LSD is partially antagonized by the mGlu2/3...

A 5-HT(2C) receptor-mediated interaction between 2,5-dimethoxy-4-methylamphetamine and citalopram in the rat.

Pharmacology, Biochemistry, and Behavior September 2004 Justin R Eckler, Chad J Reissig, R A Rabin et al.

Previous studies conducted in our laboratory have shown that acute administration of the selective serotonin re-uptake inhibitor (SSRI), citalopram, potentiates the stimulus effects of the phenethylamine hallucinogen [-]-2,5-dimethoxy-4-methylamphetamine (DOM) in the rat while neither substituting for the DOM stimulus when administered alone nor altering brain levels of DOM. The present...

Stimulus effects of three sulfur-containing psychoactive agents.

Pharmacology, Biochemistry, and Behavior August 1, 2004 Nantaka Khorana, Manik R Pullagurla, Małgorzata Dukat et al. 21 citations

Two agents gaining popularity on the illicit drug market are the phenylalkylamines 4-MTA and 2C-T-7 [or 1-(4-methylthiophenyl)-2-aminopropane and 2-(2,5-dimethoxy-4-n-propylthiophenyl)-1-aminoethane, respectively]. At this time, there exists a paucity of information on the behavioral actions of these sulfur-containing agents. The present investigation examined these agents, and the N-monomethyl...

DOI: 10.1016/j.pbb.2004.05.021 (opens in new tab) Full text (opens in new tab) Emerging sulfur-containing compounds Categorizing these substances Distinct effects Mimicked MDMA'S Effects +12

Behavioral characterization of 2-O-desmethyl and 5-O-desmethyl metabolites of the phenylethylamine hallucinogen DOM.

Pharmacology, Biochemistry, and Behavior July 2003 Justin R Eckler, Jean Chang-Fong, R A Rabin et al.

The present investigation was undertaken to test the hypothesis that known metabolites of the phenylethylamine hallucinogen 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane (DOM) are pharmacologically active. This hypothesis was tested by evaluating the ability of racemic DOM metabolites 2-O-desmethyl DOM (2-DM-DOM) and 5-O-desmethyl DOM (5-DM-DOM) to substitute for the stimulus properties of...

Anti-addictive actions of an iboga alkaloid congener: a novel mechanism for a novel treatment.

Pharmacology, Biochemistry, and Behavior June 1, 2003 Isabelle M Maisonneuve, Stanley D Glick 109 citations

18-Methoxycoronaridine (18-MC), a novel iboga alkaloid congener that decreases drug self-administration in several animal models, may be a potential treatment for multiple forms of drug abuse. In animal models, 18-MC reduced intravenous morphine, cocaine, methamphetamine and nicotine self-administration, oral alcohol and nicotine intake, and attenuated signs of opioid withdrawal, but had no...

Plant derivatives in the treatment of alcohol dependency.

Pharmacology, Biochemistry, and Behavior June 1, 2003 Amir H Rezvani, David H Overstreet, Marina Perfumi et al. 95 citations

The present review summarizes the findings of the effects of extracts of purified compounds from several plants on alcohol intake in alcohol-preferring rats. These include St. John's wort (Hypericum perforatum, HPE), kudzu (Pueraria lobata) and ibogaine (Tabernanthe iboga). Alcohol-preferring (P), Marchigian Sardinian (msP), high-alcohol-drinking (HAD), Fawn-Hooded (FH) rats were allowed to...

Plants and the central nervous system.

Pharmacology, Biochemistry, and Behavior June 2003 E A Carlini

This review article draws the attention to the many species of plants possessing activity on the central nervous system (CNS). In fact, they cover the whole spectrum of central activity such as psychoanaleptic, psycholeptic and psychodysleptic effects, and several of these plants are currently used in therapeutics to treat human ailments. Among the psychoanaleptic (stimulant) plants, those...

Nefazodone in the rat: mimicry and antagonism of [-]-DOM-induced stimulus control.

Pharmacology, Biochemistry, and Behavior May 2003 Justin R Eckler, R A Rabin, Jerrold C Winter

Nefazodone is presently marketed as an antidepressant that inhibits both serotonin (5-hydroxytryptamine, 5-HT) and norepinephrine reuptake while antagonizing pirenpirone (5-HT2) receptors. This 5-HT receptor type is believed to play a prominent role in the underlying mechanism of action of serotonergic hallucinogens. Antidepressant medications now represent the most commonly prescribed...

Characterization of the discriminative stimulus properties of centrally administered (-)-DOM and LSD.

Pharmacology, Biochemistry, and Behavior February 2003 Mireille M Doat, Richard A. Rabin, Jerrold C Winter

Despite the plausible assumption that the effects of hallucinogens predominantly arise in the central nervous system, most studies of these drugs in intact subjects have been conducted following systemic administration. The objective of the present investigation was to characterize the stimulus effects of (-)2,5-dimethoxy-4-methylamphetamine ((-)-DOM) following intracerebroventricular...

Tolerance to the disruptive effects of Delta(9)-THC on learning in rats.

Pharmacology, Biochemistry, and Behavior December 2002 M S Delatte, P J Winsauer, J M Moerschbaecher

Tolerance to the effects of the cannabinoid agonist Delta(9)-tetrahydrocannabinol (Delta(9)-THC) was characterized in rats responding under a multiple schedule of repeated acquisition and performance. During the acquisition component, subjects acquired a different three-response sequence each session, whereas in the performance component the sequence was the same each session. Responding was...

The effects of acute and subchronic treatment with fluoxetine and citalopram on stimulus control by DOM.

Pharmacology, Biochemistry, and Behavior December 2002 Jerrold C Winter, Justin R Eckler, Mireille M Doat et al.

Previous reports from our laboratory have provided evidence that acute, i.e., concurrent, treatment with selective serotonin reuptake inhibitors (SSRIs) augments the stimulus effects of indoleamine and phenethylamine hallucinogens in the rat. In the present investigation, the acute effects of fluoxetine and citalopram on stimulus control induced by (-)-2,5-dimethoxy-4-methylamphetamine (DOM)...

Effects of frequent marijuana use on memory-related regional cerebral blood flow.

Pharmacology, Biochemistry, and Behavior May 2002 Robert I Block, Daniel S O'Leary, Richard D Hichwa et al.

It is uncertain whether frequent marijuana use adversely affects human brain function. Using positron emission tomography (PET), memory-related regional cerebral blood flow was compared in frequent marijuana users and nonusing control subjects after 26+ h of monitored abstention. Memory-related blood flow in marijuana users, relative to control subjects, showed decreases in prefrontal cortex,...

Further characterization of the stimulus properties of 5,6,7,8-tetrahydro-1,3-dioxolo[4,5-g]isoquinoline.

Pharmacology, Biochemistry, and Behavior May 2002 Richard A Glennon, Richard Young, Jagadeesh B Rangisetty

This investigation is based on the premise that conformational restriction of abused phenylalkylamines in a tetrahydroisoquinoline conformation alters their pharmacology in such a manner that their original action is lost and that a new action emerges. TDIQ or 5,6,7,8-tetrahydro-1,3-dioxolo[4,5-g]isoquinoline, is a conformationally constrained phenylalkylamine that serves as a discriminative...

5-HT2A receptor-stimulated phosphoinositide hydrolysis in the stimulus effects of hallucinogens.

Pharmacology, Biochemistry, and Behavior May 2002 Richard A. Rabin, Meredith J. Regina, Mireille M Doat et al.

The role of 5-HT2A-mediated stimulation of phosphoinositide hydrolysis in the discriminative effects of hallucinogens was investigated in PC12 cells stably expressing the rat 5-HT2A receptor (PC12-5-HT2A cells). The hallucinogenic compounds, D-lysergic acid diethylamide (LSD), (-)2,5-dimethoxy-4-methylamphetamine (DOM), psilocybin, N,N-dimethyltryptamine (DMT), 5-methoxy-N,N-dimethyltryptamine...

Effect of 1-(3,4-methylenedioxyphenyl)-2-aminopropane and its optical isomers in PMMA-trained rats.

Pharmacology, Biochemistry, and Behavior May 2002 Richard A Glennon, Richard Young

1-(3,4-Methylenedioxyphenyl)-2-aminopropane (MDA) is a drug of abuse that is known to produce stimulus effects similar to those of the stimulant phenylalkylamine (+)amphetamine and the hallucinogenic phenylalkylamine 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane (DOM). Earlier, a working model was described to account for the stimulus effects produced by phenylalkylamines. Such agents can...